Watchlist Price Alert

Soleno Therapeutics Inc. (SLNO)

NASDAQ: SLNO · Real-Time Price · USD

75.25

-1.79 (-2.32%)

At close: Jun 05, 2025, 3:59 PM

75.22

-0.04%

After-hours: Jun 05, 2025, 04:04 PM EDT

Soleno Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-1.55B	1.45M
Cost of Revenue	n/a	1.96M	2.21M	2.21M	2.19M	2.3M	1.92M	1.61M	1.51M
Gross Profit	n/a	-1.96M	-2.21M	-2.21M	-2.19M	-2.3M	-1.92M	-1.55B	-58.52K
Operating Income	-184.43M	-41.38M	-24.4M	-31.53M	-36.29M	-23.49M	-14.3M	-12.17M	-13.61M
Interest Income	n/a	2.58M	300K	110K	13K	154K	n/a	n/a	n/a
Pretax Income	-175.85M	-38.99M	-24.07M	-30.91M	-24.64M	-30.77M	-11.84M	-13.72M	-12.04M
Net Income	-175.85M	-38.99M	-20.32M	-29.56M	-15.38M	-35.91M	-13.34M	-15.67M	-12.07M
Selling & General & Admin	105.86M	13.48M	9.84M	10.81M	8.76M	6.93M	6.56M	6.61M	8.37M
Research & Development	78.57M	25.19M	15.27M	21.45M	23.19M	16.27M	7.18M	3.07M	5.18M
Other Expenses	n/a	2.71M	n/a	n/a	4.34M	289K	6K	-585.95K	-100.52K
Operating Expenses	187.67M	41.38M	25.11M	32.26M	31.95M	23.2M	13.73M	9.68M	13.55M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	62K	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	25.73K	1.63M
Cost & Expenses	n/a	41.38M	25.11M	32.26M	31.95M	23.2M	13.73M	9.68M	15.06M
Income Tax Expense	n/a	n/a	-3.75M	-1.35M	-9.26M	5.14M	2.52M	-1.65M	21.7K
Shares Outstanding (Basic)	40.18M	16.49M	8.4M	5.32M	4.17M	2.28M	1.4M	598.52K	206.77K
Shares Outstanding (Diluted)	40.18M	16.49M	8.4M	5.32M	4.17M	2.28M	1.4M	598.52K	206.77K
EPS (Basic)	-4.38	-2.36	-2.42	-5.56	-3.68	-15.78	-9.54	-26.18	-58.35
EPS (Diluted)	-4.38	-2.36	-2.42	-5.56	-3.68	-15.78	-9.54	-26.18	-58.35
EBITDA	-173.63M	-37.03M	-21.86M	-28.7M	-30M	-28.48M	-9.92M	-8.07M	-6.72M
EBIT	-175.62M	-38.99M	-24.07M	-32.26M	-31.95M	-23.2M	-13.73M	-13.44M	-6.74M
Depreciation & Amortization	n/a	1.96M	2.21M	2.21M	2.19M	2.3M	1.92M	1.61M	19.7K